| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.1B | $0.2B | $0.2B | $0.3B | $0.2B | $0.2B | $0.2B |
| EPS (Basic) | $4.67 | $3.48 | $4.16 | $5.50 | $6.29 | $3.87 | $5.59 | $5.26 |
| EPS (Diluted) | $4.63 | $3.46 | $4.14 | $5.48 | $6.25 | $3.86 | $5.56 | $5.23 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $24.2B | $23.6B | $23.7B | $23.6B | $22.8B | $20.6B | $18.1B | $17.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.9B | $0.8B | $1.0B | $0.4B | — | — | $0.6B | $0.5B |
| Total Liabilities | $22.3B | $21.9B | $22.3B | $22.3B | $21.2B | $19.2B | $16.8B | $15.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.9B | $1.7B | $1.4B | $1.3B | $1.6B | $1.4B | $1.3B | $1.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.2B | $0.2B | $0.3B | $0.4B | $0.1B | $0.2B | — |
| Investing Cash Flow | $-0.4B | $0.0B | $0.6B | $-1.3B | $-2.4B | $-2.4B | $-0.8B | — |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | — | — |
| Financing Cash Flow | $0.4B | $-0.4B | $-0.1B | $0.8B | $2.0B | $2.3B | $0.6B | — |